Abstract
Hodgkin’s disease (HD) is a malignant disease morphologically characterized by the presence of multinucleated Reed-Sternberg (RS) and mononuclear Hodgkin’s cells (H) in a stromal background consisting of lymphocytes, plasma cells, histiocytic cells, and eosinophils. Both the etiology of HD and the precursor identity of its presumed malignant component, the RS and H cells, have remained uncertain. Various cell types have been proposed as the originator of HD, including lymphoid cells, mononuclear phagocytes, interdigitating reticulum cells, follicular dentritic cells, and granulopoietic cells. Unfortunately, the analysis of RS-H cells is hampered by the scarcity of this neoplastic component and contamination with bystander cells in HD-involved tissues. Recently, a number of cell lines have been established from tissues or pleural effusions of patients with HD, mostly of the nodular sclerosis variant. These in vitro cultured cells presumably represent the in vivo RS-H cells, as they have identical or very similar characteristic features. They might therefore be operationally regarded as in vitro representatives of RS-H cells. A number of features of HD are consistent with those of a tumor of cytokine-producing cells, including occurrence of B symptoms, sclerosis, eosinophilia, and polykaryon formation. The present study thus aimed at evaluating the spectrum of cytokines released by the two well-defined HD-derived permanent cell lines HDLM-2 [1] and KM-H2 [2]. A broad panel of cytokines was analyzed at the messenger RNA (mRNA) and protein level including granulocyte-macrophage colony-stimulating factor (GM-CSF), Granulocyte (G)-CSF, macrophage (M)-CSF, interleukin1α and -1β (IL-lα, -1β), IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-10, leukemia inhibitory factor (LIF), tumor necrosis factor alpha (TNF-α), TNF-β, transforming growth factor beta (TGF-β), interferon gamma (IFN-γ), monocyte chemoattractant and activating factor/JE (MCAF/JE), and the early response genes c-jun and c-fos, known to be involved in cytokine signaling. In addition, expression of the p55 and p75 IL-2 receptor chains, of the p80 IL-6 receptor, and of the M-CSF receptor (c-fms) was assessed by Northern blotting using specific complementary DNA (cDNA) probes. The presence of transcription factors known to bind to consensus sequences in regulatory 5’ flanking regions of many cytokine genes [3] such as the activation protein 1 (AP 1), the nuclear factor kappa B (NFκB), as well as the nuclear factor in activated T cells 1 (NFAT 1), previously shown to be a T-cell specific molecule [4], were analyzed in nuclear extracts of both cell lines, of T cells, and of monocytes by electrophoretic mobility shift assay (EMSA).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Drexler HG, Gaedicke G, Lok MS, Diehl V, Minowada J (1986) Hodgkin’s disease derived cell lines HDLM-2 and L-428: comparison of morphology, immunological and isoenzyme profiles. Leuk Res 10: 487–500
Kamesaki H, Fukuhara S, Tatsumi E, Uchino H, Yamabe H, Miwa H, Shirakawa S, Hatanaka S, Honjo T (1986) Cytochemical, immunologic, chromosomal and molecular genetic analysis of a novel cell line derived from Hodgkin’s disease. Blood 68: 285–292
Taniguchi T (1988) Regulation of cytokine gene expression. Annu Rev Immunol 6: 439
Shaw JP, Utz PJ, Durand DB, Toole JJ, Emmel EA, Crabtree GR (1988) Identification of a putative regulator of early T cell activation genes. Science 241: 202–205
Oster W, Lindemann A, Horn S, Mertelsmann R, Herrmann F (1987) Tumor necrosis factor (TNF)-alpha but not TNF-beta induces secretion of colony stimulating factor for macrophages (CSF-1) by human monocytes. Blood 70: 1700–1703
Herrmann F, Cannistra SA, Lindemann A, Blohm D, Rambaldi A, Mertelsmann RH, Griffin JD (1989) Functional consequences of monocyte IL-2 receptor expression: induction of IL-113 secretion by IFN-g and IL-2. J Immunol 142: 139–143
Ohlsson H, Edlund T (1986) Sequence-specific interactions of nuclear factors with the insulin gene enhancer. Cell 45: 35–44
Brach MA, Henschler R, Mertelsmann RH, Herrmann F (1991) Regulation of M-CSF expression by M-CSF: role of protein kinase C and transcription factor NFiB. Pathobiology 59: 284–288
Sen R, Baltimore D (1986) Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46: 705–716
Molitor JA, Walker WH, Doerre S, Ballard DW, Greene WC (1990) NF-KB: a family of inducible and differentially expressed enhancer-binding proteins in human T cells. Proc Natl Acad Sci USA 87: 10028–10034
Rollins BJ, Stier P, Ernst T, Wong GG (1989) The human homolog of the JE gene encodes a monocyte secretory protein. Mol Cell Biol 9: 4687–4695
Drexler HG, Jones DB, Diehl V, Minowada J (1989) Is the Hodgkin’s cell a T- or B-lymphocyte? Recent evidence from geno-and immunophenotypic analysis and in-vitro cell lines. Hematol Oncol 7: 95–113
Drexler HG, Amlot PL, Minowada J (1987) Hodgkin’s disease-derived cell lines conflicting clues for the origin of Hodgkin’s disease? Leukemia 1: 629–637
Drexler HG, Leber BF, Norton J, Yaxley J, Tatsumi E, Hoffbrand AV, Minowada J (1988) Genotypes and immunophenotypes of Hodgkin’s disease-derived cell lines. Leukemia 2: 371–376
Cerdan C, Martin Y, Brailly H, Courcoul M, Flavetta S, Costello R, Mawas C, Birg F, Olive D (1991) IL-la is produced by T lymphocytes activated via the CD2 plus CD28 pathways. J Immunol 146: 560–564
Hallet MM, Praloran V, Vie H, Peyrat MA, Wong G, Witek-Giannotti J, Soulillou JP, Moreau JF (1991) Macrophage colony-stimulating factor (CSF-1) gene expression in human T-lymphocyte clones. Blood 77: 780–786
Rettenmier CW, Sacca R, Furman WL, Roussel MF, Holt JT, Nienhuis AW, Stanley ER, Sherr CJ (1986) Expression of the human c-fms proto-oncogene product (colony-stimulating factor-1 receptor) on peripheral blood mononuclear cells and choriocarcinoma cell lines. J Clin Invest 77: 1740–1746
Horiguchi J, Sherman ML, Sampson-Johannes A, Weber BL, Kufe DW (1988) CSF-1 and c-fms gene expression in human carcinoma cell lines. Biochem Biophys Res Commun 157: 395–401
Kacinski BM, Carter D, Mittal K, Kohorn EI, Shaeffer R, Bloodgood R, Donahue J, Donofrio L, Edwards R, Schwartz PE, Chambers JT, Chambers SK (1988) High level expression of fms proto-oncogene mRNA is observed in clinically aggressive human endometrial adenocarcinomas. Int J Radiat Oncol Biol Phys 15: 823–829
Paietta E, Racevskis J, Stanley R, Andreeff M, Papenhausen P, Wiemik PH (1990) Expression of the macrophage growth factor, CSF-1, and its receptor c-fins by a Hodgkin’s disease-derived cell line and its variants. Cancer Res 50: 2049–2055
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer-Verlag, Berlin Heidelberg
About this paper
Cite this paper
Gruss, HJ., Brach, M.A., Mertelsmann, R., Herrmann, F. (1992). The Expression Pattern of Cytokine Genes and Cytokine Receptors by Hodgkin’s Disease-Derived Cell Lines HDLM-2 and KM-H2 Resembles That of Activated T Cells. In: Freund, M., Link, H., Schmidt, R.E., Welte, K. (eds) Cytokines in Hemopoiesis, Oncology, and AIDS II. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-48715-6_29
Download citation
DOI: https://doi.org/10.1007/978-3-642-48715-6_29
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-55242-0
Online ISBN: 978-3-642-48715-6
eBook Packages: Springer Book Archive